Skip to main content
Earnings Labs
GRAIL Inc. logo

GRAIL Inc. (GRAL)

NASDAQ·Healthcare·Biotechnology

$71.20

+1.32%

Mkt Cap $2.76B

Analyst Ratings

Buy

4

Hold

3

Sell

0

Price Target (16 analysts)

$74.43

Range $56.00$130.00

Implied Upside

+4.5%

Consensus $74.43 vs current $71.20